Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

albuminuria

  • Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature
    You have accessRestricted Access
    Prevalence and Risk Factors for Kidney Disease and Elevated BP in 2-Year-Old Children Born Extremely Premature
    Sangeeta Hingorani, Robert Schmicker, Kaashif A. Ahmad, Ivan D. Frantz, Dennis E. Mayock, Edmund F. La Gamma, Mariana Baserga, Janine Y. Khan, Maureen M. Gilmore, Tonya Robinson, Patrick Brophy, Patrick J. Heagerty, Sandra E. Juul, Stuart Goldstein and David Askenazi; for the PENUT Trial Consortium
    CJASN August 2022, 17 (8) 1129-1138; DOI: https://doi.org/10.2215/CJN.15011121
    Add to Selected Citations
  • You have accessRestricted Access
    Moving from Evidence to Implementation of Breakthrough Therapies for Diabetic Kidney Disease
    Katherine R. Tuttle, Leslie Wong, Wendy St. Peter, Glenda Roberts, Janani Rangaswami, Amy Mottl, Alan S. Kliger, Raymond C. Harris, Patrick O. Gee, Kevin Fowler, David Cherney, Frank C. Brosius, Christos Argyropoulos and Susan E. Quaggin; on behalf of the Diabetic Kidney Disease Collaborative Task Force
    CJASN July 2022, 17 (7) 1092-1103; DOI: https://doi.org/10.2215/CJN.02980322
    Add to Selected Citations
  • Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations
    Open Access
    Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations
    Jean-Tristan Brandenburg, Melanie A. Govender, Cheryl A. Winkler, Palwende Romuald Boua, Godfred Agongo, June Fabian and Michèle Ramsay
    CJASN June 2022, 17 (6) 798-808; DOI: https://doi.org/10.2215/CJN.14321121
    Add to Selected Citations
  • Open Access
    The Role of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists in the Prevention and Treatment of Diabetic Kidney Disease
    Kalie L. Tommerdahl, Jessica Kendrick and Petter Bjornstad
    CJASN June 2022, 17 (6) 905-907; DOI: https://doi.org/10.2215/CJN.00020122
    Add to Selected Citations
  • You have accessRestricted Access
    Value-Based Care in Chronic Kidney Disease
    Allison C. Reaves and Daniel E. Weiner
    CJASN January 2022, 17 (1) 14-16; DOI: https://doi.org/10.2215/CJN.15031121
    Add to Selected Citations
  • You have accessRestricted Access
    Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease
    Alberto Ortiz and Beatriz Fernandez-Fernandez
    CJASN December 2021, 16 (12) 1775-1778; DOI: https://doi.org/10.2215/CJN.13601021
    Add to Selected Citations
  • The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function
    You have accessRestricted Access
    The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function
    Simke W. Waijer, Ron T. Gansevoort, George L. Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, Donald E. Kohan, Dalane W. Kitzman, Hirofumi Makino, John J.V. McMurray, Vlado Perkovic, Sheldon Tobe, Hans-Henrik Parving, Dick de Zeeuw and Hiddo J.L. Heerspink
    CJASN December 2021, 16 (12) 1824-1832; DOI: https://doi.org/10.2215/CJN.07340521
    Add to Selected Citations
  • Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes
    You have accessRestricted Access
    Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes
    Sun H. Kim, Irwin G. Brodsky, Ranee Chatterjee, Sangeeta R. Kashyap, William C. Knowler, Emilia Liao, Jason Nelson, Richard Pratley, Neda Rasouli, Ellen M. Vickery, Mark Sarnak, Anastassios G. Pittas and D2d Research Group
    CJASN August 2021, 16 (8) 1201-1209; DOI: https://doi.org/10.2215/CJN.00420121
    Add to Selected Citations
  • Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
    You have accessRestricted Access
    Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
    Meg Jardine, Zien Zhou, Hiddo J. Lambers Heerspink, Carinna Hockham, Qiang Li, Rajiv Agarwal, George L. Bakris, Christopher P. Cannon, David M. Charytan, Tom Greene, Adeera Levin, Jing-Wei Li, Brendon L. Neuen, Bruce Neal, Richard Oh, Megumi Oshima, Carol Pollock, David C. Wheeler, Dick de Zeeuw, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey and Vlado Perkovic
    CJASN March 2021, 16 (3) 384-395; DOI: https://doi.org/10.2215/CJN.15260920
    Add to Selected Citations
  • Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
    Open Access
    Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
    John P. Hanrahan, Ian H. de Boer, George L. Bakris, Phebe J. Wilson, James D. Wakefield, Jelena P. Seferovic, Jennifer G. Chickering, Yueh-tyng Chien, Kenneth Carlson, Michael D. Cressman, Mark G. Currie, G. Todd Milne and Albert T. Profy
    CJASN January 2021, 16 (1) 59-69; DOI: https://doi.org/10.2215/CJN.08410520
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire